WK
Walter V Klemp
CEO and PresidentDirector

Walter V Klemp insider trades: Moleculin Biotech (MBRX) stock buys and sales

CEO and President, Moleculin Biotech Last trade Jun 23, 2025 43 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
7
Open-market trades
since 2017
3
Companies
last trade 2025

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Walter reports to the SEC

Open-market buys and sales

7 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jun 23, 2025MBRX↑ Buy$250K
Dec 26, 2023MBRX↑ Buy$130K
Nov 25, 2022MBRX↑ Buy$58K
Nov 21, 2022MBRX↑ Buy$26K
Nov 17, 2022MBRX↑ Buy$108K
Aug 16, 2017MBRX↓ Sell$170K
May 11, 2017MBRX↑ Buy$10K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Walter V Klemp's insider trades

Walter V Klemp is CEO and President at Moleculin Biotech (MBRX). Since May 11, 2017, Walter has reported 6 open-market purchases worth $581K and 1 sale worth $170K on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include option exercises (20 filings), shares withheld for taxes (20 filings), grants and awards (16 filings), shares returned to the company (2 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MBRX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.